10.25384/SAGE.7343366.v1
Yuksel Urun
Yuksel
Urun
H Arzu Yasar
H Arzu
Yasar
Hande Turna
Hande
Turna
Ece Esin
Ece
Esin
A Murat Sedef
A Murat
Sedef
Ali Alkan
Ali
Alkan
Berna Oksuzoglu
Berna
Oksuzoglu
Nuriye Ozdemir
Nuriye
Ozdemir
MA Nahit Sendur
MA Nahit
Sendur
Ahmet Sezer
Ahmet
Sezer
Saadettin Kılıckap
Saadettin
Kılıckap
Gungor Utkan
Gungor
Utkan
Tulay Akman
Tulay
Akman
Hakan Akbulut
Hakan
Akbulut
Ismail Celik
Ismail
Celik
Huseyin Abalı
Huseyin
Abalı
Supplemental material for Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study
SAGE Journals
2018
Ipilimumab
melanoma
prognostic factors
absolute lymphocytes count
2018-11-06 12:00:00
Journal contribution
https://sage.figshare.com/articles/journal_contribution/Supplemental_material_for_Prognostic_factors_for_survival_in_patients_with_metastatic_malign_melanoma_treated_with_ipilimumab_Turkish_Oncology_Group_study/7343366
<p>Supplemental material for Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study by Yuksel Urun, H Arzu Yasar, Hande Turna, Ece Esin, A Murat Sedef, Ali Alkan, Berna Oksuzoglu, Nuriye Ozdemir, MA Nahit Sendur, Ahmet Sezer, Saadettin Kılıckap, Gungor Utkan, Tulay Akman, Hakan Akbulut, Ismail Celik and Huseyin Abalı in Journal of Oncology Pharmacy Practice</p>